Healthcare provider profile · identity verified

Luiz C Coelho, MD

Internal Medicine · ALBANY, NY · NPI 1164564514

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	275	64
Atorvastatin Calcium	Atorvastatin Calcium	261	91
Levothyroxine Sodium	Levothyroxine Sodium	245	69
Gabapentin	Gabapentin	233	55
Furosemide	Furosemide	150	48
Amlodipine Besylate	Amlodipine Besylate	146	49
Tamsulosin Hcl	Tamsulosin Hcl	140	49
Sertraline Hcl	Sertraline Hcl	129	36
Metoprolol Succinate	Metoprolol Succinate	127	45
Trazodone Hcl	Trazodone Hcl	118	38
Potassium Chloride	Potassium Chloride	117	42
Metoprolol Tartrate	Metoprolol Tartrate	98	38
Pantoprazole Sodium	Pantoprazole Sodium	96	47
Losartan Potassium	Losartan Potassium	95	29
Pravastatin Sodium	Pravastatin Sodium	85	17
Clopidogrel	Clopidogrel Bisulfate	77	27
Omeprazole	Omeprazole	74	32
Spironolactone	Spironolactone	74	17
Carvedilol	Carvedilol	71	23
Rosuvastatin Calcium	Rosuvastatin Calcium	71	13
Escitalopram Oxalate	Escitalopram Oxalate	69	19
Mirtazapine	Mirtazapine	69	16
Bumetanide	Bumetanide	66	30
Metformin Hcl	Metformin Hcl	63	15
Citalopram Hbr	Citalopram Hydrobromide	57	13
Gemtesa	Vibegron	56	suppressed
Lisinopril	Lisinopril	56	23
Enoxaparin Sodium	Enoxaparin Sodium	55	24
Finasteride	Finasteride	54	17
Divalproex Sodium	Divalproex Sodium	51	11
Latanoprost	Latanoprost	49	17
Ezetimibe	Ezetimibe	48	11
Carbidopa-Levodopa	Carbidopa/Levodopa	46	11
Quetiapine Fumarate	Quetiapine Fumarate	46	16
Tramadol Hcl	Tramadol Hcl	45	30
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Allopurinol	Allopurinol	42	13
Trulicity	Dulaglutide	39	suppressed
Buspirone Hcl	Buspirone Hcl	37	15
Prednisone	Prednisone	37	18
Nifedipine Er	Nifedipine	36	12
Atenolol	Atenolol	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	14
Famotidine	Famotidine	35	17
Hydralazine Hcl	Hydralazine Hcl	34	16
Alprazolam	Alprazolam	33	16
Midodrine Hcl	Midodrine Hcl	32	14
Albuterol Sulfate Hfa	Albuterol Sulfate	31	29
Sucralfate	Sucralfate	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	11
Cefuroxime	Cefuroxime Axetil	30	24
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	30
Sps	Sodium Polystyrene Sulfon/Sorb	30	19
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Entresto	Sacubitril/Valsartan	26	11
Fluticasone Propionate	Fluticasone Propionate	26	18
Olanzapine	Olanzapine	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Clonazepam	Clonazepam	25	13
Oxycodone Hcl	Oxycodone Hcl	25	22
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Morphine Sulfate	Morphine Sulfate	23	16
Clonidine Hcl	Clonidine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Levofloxacin	Levofloxacin	22	19
Lorazepam	Lorazepam	22	16
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Klor-Con 10	Potassium Chloride	21	suppressed
Levetiracetam	Levetiracetam	21	11
Metolazone	Metolazone	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	11
Baclofen	Baclofen	19	suppressed
Cyclosporine	Cyclosporine	19	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	17	15
Ondansetron Hcl	Ondansetron Hcl	17	13
Budesonide	Budesonide	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nadolol	Nadolol	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	12
Celecoxib	Celecoxib	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lumigan	Bimatoprost	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Doxepin Hcl	Doxepin Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nystatin	Nystatin	12	11
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Restasis	Cyclosporine	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Clonidine	Clonidine	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lithium Carbonate Er	Lithium Carbonate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error